A citation-based method for searching scientific literature


List of co-cited articles
34 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A Thorough QTc Study Confirms Early Pharmacokinetics/QTc Modeling: A Supratherapeutic Dose of Omarigliptin, a Once-Weekly DPP-4 Inhibitor, Does Not Prolong the QTc Interval.
Daniel A Tatosian, Nadia Cardillo Marricco, Xiaoli Shirley Glasgow, Bruce DeGroot, Katherine Dunnington, Laura George, Isaias Noel Gendrano, Amy O Johnson-Levonas, Dennis Swearingen, Eunkyung Kauh. Clin Pharmacol Drug Dev 2016
10
80


Pharmacokinetics and Pharmacodynamics of Omarigliptin, a Once-Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, After Single and Multiple Doses in Healthy Subjects.
Rajesh Krishna, Carol Addy, Daniel Tatosian, Xiaoli S Glasgow, Isaias Noel Gendrano Iii, Martine Robberechts, Wouter Haazen, J N de Hoon, Marleen Depré, Ashley Martucci,[...]. J Clin Pharmacol 2016
18
80

Single and multiple dose pharmacokinetics and pharmacodynamics of omarigliptin, a novel, once-weekly dipeptidyl peptidase-4 inhibitor, in healthy Japanese men.
Saori Tsuchiya, Evan Friedman, Carol Addy, Akira Wakana, Daniel Tatosian, Yuki Matsumoto, Hideyo Suzuki, Eunkyung Kauh. J Diabetes Investig 2017
12
80

Pharmacokinetic and Pharmacodynamic Effects of Multiple-dose Administration of Omarigliptin, a Once-weekly Dipeptidyl Peptidase-4 Inhibitor, in Obese Participants With and Without Type 2 Diabetes Mellitus.
Carol Addy, Daniel Tatosian, Xiaoli S Glasgow, Isaias N Gendrano, Eunkyung Kauh, Ashley Martucci, Amy O Johnson-Levonas, Diana Selverian, Catherine Z Matthews, Marie Gutierrez,[...]. Clin Ther 2016
12
80


Omarigliptin: first global approval.
Celeste B Burness. Drugs 2015
23
60

Omarigliptin for the treatment of type 2 diabetes mellitus.
Philip M S Evans, Stephen C Bain. Expert Opin Pharmacother 2016
12
60

Omarigliptin (MK-3102): a novel long-acting DPP-4 inhibitor for once-weekly treatment of type 2 diabetes.
Tesfaye Biftu, Ranabir Sinha-Roy, Ping Chen, Xiaoxia Qian, Dennis Feng, Jeffrey T Kuethe, Giovanna Scapin, Ying Duo Gao, Youwei Yan, Davida Krueger,[...]. J Med Chem 2014
91
60

Effects of Age, Sex, and Obesity on the Single-Dose Pharmacokinetics of Omarigliptin in Healthy Subjects.
Carol Addy, Daniel A Tatosian, Xiaoli S Glasgow, Isaias Noel Gendrano, Christine McCrary Sisk, Eunkyung A Kauh, S Aubrey Stoch, John A Wagner. Clin Pharmacol Drug Dev 2016
4
75

Sitagliptin and liraglutide reversed nigrostriatal degeneration of rodent brain in rotenone-induced Parkinson's disease.
Ghada A Badawi, Mai A Abd El Fattah, Hala F Zaki, Moushira I El Sayed. Inflammopharmacology 2017
38
60

Absorption, metabolism and excretion of [14C]omarigliptin, a once-weekly DPP-4 inhibitor, in humans.
Shiyao Xu, Dan Tatosian, Ian Mcintosh, Maria Caceres, Catherine Matthews, Koppara Samuel, Diana Selverian, Sanjeev Kumar, Eunkyung Kauh. Xenobiotica 2018
7
60

Safety and Efficacy of Omarigliptin (MK-3102), a Novel Once-Weekly DPP-4 Inhibitor for the Treatment of Patients With Type 2 Diabetes.
Wayne H-H Sheu, Ira Gantz, Menghui Chen, Shailaja Suryawanshi, Arpana Mirza, Barry J Goldstein, Keith D Kaufman, Samuel S Engel. Diabetes Care 2015
40
40


Microbiota modulation counteracts Alzheimer's disease progression influencing neuronal proteolysis and gut hormones plasma levels.
Laura Bonfili, Valentina Cecarini, Sara Berardi, Silvia Scarpona, Jan S Suchodolski, Cinzia Nasuti, Dennis Fiorini, Maria Chiara Boarelli, Giacomo Rossi, Anna Maria Eleuteri. Sci Rep 2017
148
40



Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration.
A I Duarte, E Candeias, S C Correia, R X Santos, C Carvalho, S Cardoso, A Plácido, M S Santos, C R Oliveira, P I Moreira. Biochim Biophys Acta 2013
82
40



Parkinson's Disease, Diabetes and Cognitive Impairment.
Mohammad R Ashraghi, Gennaro Pagano, Sotirios Polychronis, Flavia Niccolini, Marios Politis. Recent Pat Endocr Metab Immune Drug Discov 2016
32
40


Determination of pazopanib (GW-786034) in mouse plasma and brain tissue by liquid chromatography-tandem mass spectrometry (LC/MS-MS).
Mukul Minocha, Varun Khurana, Ashim K Mitra. J Chromatogr B Analyt Technol Biomed Life Sci 2012
31
40

Oral Administration of Sitagliptin Activates CREB and Is Neuroprotective in Murine Model of Brain Trauma.
Brian DellaValle, Gitte S Brix, Birgitte Brock, Michael Gejl, Jørgen Rungby, Agnete Larsen. Front Pharmacol 2016
13
40

Non-motor symptoms of Parkinson's disease: the patient's perspective.
Kieran C Breen, Gerda Drutyte. J Neural Transm (Vienna) 2013
40
40



Drug repositioning: an opportunity to develop novel treatments for Alzheimer's disease.
Anne Corbett, Gareth Williams, Clive Ballard. Pharmaceuticals (Basel) 2013
24
40

Drug Repositioning Through Network Pharmacology.
Hao Ye, Jia Wei, Kailin Tang, Ritchie Feuers, Huixiao Hong. Curr Top Med Chem 2016
20
40

Saxagliptin: a novel antiparkinsonian approach.
Noha N Nassar, Muhammad Y Al-Shorbagy, Hany H Arab, Dalaal M Abdallah. Neuropharmacology 2015
53
40

Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent.
Bassam M Ayoub, Shereen Mowaka, Marwa M Safar, Nermeen Ashoush, Mona G Arafa, Haidy E Michel, Mariam M Tadros, Mohamed M Elmazar, Shaker A Mousa. Sci Rep 2018
17
40



Enhanced Extraction Technique of Omarigliptin from Human Plasma-Applied to Biological Samples from Healthy Human Volunteers.
Shereen Mowaka, Nermeen Ashoush, Mariam Tadros, Noha El Zahar, Bassam Ayoub. Molecules 2020
2
100




Synchronous fluorescence determination of urinary 1-hydroxypyrene, beta-naphthol and 9-hydroxyphenanthrene based on the sensitizing effect of beta-cyclodextrin.
Hong-Mei Yang, Yong-Sheng Wang, Jun-Hong Li, Gui-Rong Li, Ying Wang, Xuan Tan, Jin-Hua Xue, Xi-Lin Xiao, Rong-Hui Kang. Anal Chim Acta 2009
22
20





Micellar solubilization of drugs.
Carlota Oliveira Rangel-Yagui, Adalberto Pessoa, Leoberto Costa Tavares. J Pharm Pharm Sci 2005
232
20


Development and validation of sensitive liquid chromatography/tandem mass spectrometry method for quantification of bendamustine in mouse brain tissue.
Lei He, John C Grecula, Yonghua Ling, Michael D Enzerra, Mario Ammirati, Kari Kendra, Robert Cavaliere, Nina Mayr, John McGregor, Thomas Olencki,[...]. J Chromatogr B Analyt Technol Biomed Life Sci 2012
10
20

Possible mechanisms relating diet and risk of colon cancer.
W R Bruce, A Giacca, A Medline. Cancer Epidemiol Biomarkers Prev 2000
180
20

DPP4 in anti-tumor immunity: going beyond the enzyme.
Kei Ohnuma, Ryo Hatano, Chikao Morimoto. Nat Immunol 2015
16
20

Repositioning of proton pump inhibitors in cancer therapy.
Zhen-Ning Lu, Bing Tian, Xiu-Li Guo. Cancer Chemother Pharmacol 2017
33
20

Gas chromatographic method using nitrogen-phosphorus detection for the measurement of tramadol and its O-desmethyl metabolite in plasma and brain tissue of mice and rats.
Q Tao, D J Stone, M R Borenstein, V Jean-Bart, E E Codd, T P Coogan, D Desai-Krieger, S Liao, R B Raffa. J Chromatogr B Biomed Sci Appl 2001
28
20

Drug repositioning: playing dirty to kill pain.
Leandro Francisco Silva Bastos, Márcio Matos Coelho. CNS Drugs 2014
27
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.